GuptaAKNicolK. The use of sulfur in dermatology. J Drugs Dermatol2004;3:427–31.
2.
AkhavanABershadS. Topical acne drugs: Review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol2003;4:473–92, doi:10.2165/00128071-200304070-00004.
3.
PonkaD. Approach to managing patients with sulfa allergy: Use of antibiotic and nonantibiotic sulfonamides. Can Fam Physician2006;52:1434–8.
4.
DibbernDAJrMontanaroA. Allergies to sulfonamide antibiotics and sulfur-containing drugs. Ann Allergy Asthma Immunol2008; 100:91–100, doi:10.1016/S1081-1206(10)60415-2.
5.
GenvertGICohenEJDonnenfeldED. Erythema multiforme after use of topical sulfacetamide. Am J Ophthalmol1985;99:465–8.
GottschalkHRStoneOJ. Stevens-Johnson syndrome from ophthalmic sulfonamide. Arch Dermatol1976;112:513–4, doi:10.1001/archderm.1976.01630280041010.
8.
StromBLSchinnarRApterAJ. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med2003;349:1628–35, doi:10.1056/NEJMoa022963.
9.
HemstreetBAPageRL2nd.Sulfonamide allergies and outcomes related to use of potentially cross-reactive drugs in hospitalized patients. Pharmacotherapy2006;26:551–7, doi:10.1592/phco.26.4.551.
10.
JohnsonKKGreenDLRifeJPLimonL. Sulfonamide cross-reactivity: Fact or fiction?Ann Pharmacother2005;39:290–301, doi:10.1345/aph.1E350.